Welcome to CREANT!

CREANT is the acronym of the Center for Radiopharmaceuticals Antwerp.

What we do

We create innovative radiopharmaceutical solutions that will improve the lives of cancer patients around the globe.

Our mission

CREANT’s mission is to ensure that the right cancer treatment is given to the right patient at the right time. By developing radiopharmaceuticals that target specific cancer markers we aim to provide an individually tailored therapeutic intervention.

Creating innovative radiopharmaceuticals for tomorrow’s theranostics.

News

Publication

Our team has developed a novel immuno-PET imaging tool that can help tailoring cancer therapies. Check out our latest publication.

READ MORE

PRISMAP

The European medical isotope programme – PRISMAP – has launched. This consortium aims to fast-track nuclear medicine research. Check the website!

READ MORE

Welcome!

The website for the Center for Radiopharmaceuticals Antwerp (CREANT) was just launched. More news coming soon.

READ MORE

Our partners

University of Antwerp
Molecular Imaging Center Antwerp (MICA)
Antwerp University Hospital (UZA)